Lymph nodes had a significantly better response than lung, pleural, and liver lesions in NSCLC and MMR-D tumors (20), and liver lesions exhibited the poorest response to PD-1 blockade (17, 20). This evidence concerns the gene PDCD1 and non-small cell lung carcinoma.